• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Development of the dsRNAs as an Anti-Tick Biological Agent

Jinlin Zhou of the Shanghai Veterinary Research Institute in China will develop anti-tick biological agents composed of double-stranded (ds) RNAs targeting two selected tick proteins to control the dominant tick species Rhiphicephalus haemaphysaloides, which causes human and animal diseases in south Asian countries. Previous control approaches using pesticides or vaccines have had limited success. Long dsRNAs, which silence target genes, have previously been used successfully to control a tick infestation in cattle. Zhou has selected two candidate proteins in R. haemaphysaloides, P0, which is required for viability, and Rhipilin-1, which is required for the tick to attach to the host. Zhou will synthesize dsRNAs against these proteins and test different liposome types and conditions for optimal delivery into the ticks, and evaluate the effect of the dsRNAs on tick survival and feeding.

More information about The One Health Concept: Bringing Together Human and Animal Health for New Solutions (Round 11)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.